CroíValve

CroíValve is an early-stage medical device company dedicated to developing minimally invasive devices for the treatment of tricuspid regurgitation. Located in Dublin, Ireland, the company combines extensive clinical, technical, and commercial expertise, leveraging technology from the Trinity College Bioengineering Center. CroíValve is developing a minimally invasive device to treat "tricuspid regurgitation," which can be delivered via a vein to the right ventricle. The device fills the gap between the valve leaflets, thereby preventing regurgitation. This solution allows for rapid and cost-effective treatment without the need for prolonged hospitalization.